Use of novel lung injury markers to predict graft dysfunction after lung transplantation

Use of novel lung injury markers to predict graft dysfunction after lung transplantation - Lung injury markers

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34782

Enrollment

Registered

2010-05-27

Start date

2011-04-08

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic bronchitis Chronic obstructive pulmonary disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age >

Exclusion criteria

Exclusion criteria: Hyperacute rejection Venous anastomotic obstruction Cardiogenic pulmonary edema Pneumonia (both viral and bacterial pneumonias will be considered)

Design outcomes

Primary

Measure	Time frame
The primary endpoint is primary graft dysfunction in the first 72 hours as defined by a classification system from the international society for heart and lung transplantation.	—

Secondary

Measure	Time frame
1. Assessment of biomarkers, measured during and post operation (in the recipient), that correlates with the graft function after lung transplantation. 2. Assessment of biomarkers, measured during and post operation (in the recipient), that quantifies primary graft dysfunction.	—

Countries

Netherlands

Outcome results